Small Canadian firm hopeful for U.S. flu vaccine contract next year

02/23/2005 | Reuters

ID Biomedical may not be able to sell its flu vaccine to the U.S. in time for the current season or for the 2005-2006 season, but CEO Tony Holler said he is optimistic the firm will get approval to supply Fluviral for the 2006-2007 flu season. The FDA still needs to inspect the company's facilities and approve its proposals for clinical trials for its vaccine.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA